Detection of p53 antigen expression in cytologic preparations of ovarian carcinomas.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Anticancer Research

• Publication date

  1994-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8067702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 Immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix

  1993cited by this paper
• p53 accumulation in ovarian carcinomas and its prognostic implications.

  1993cited by this paper
• p53 gene mutations and protein accumulation in human ovarian cancer.

  1993cited by this paper
• Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

  1993cited by this paper
• Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.

  1992cited by this paper
• Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library.

  1992cited by this paper
• Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.

  1992cited by this paper
• Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• p53 mutations in ovarian cancer: a late event?

  1991cited by this paper
• Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.

  1991cited by this paper
• Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas.

  1991cited by this paper
• Overexpression and mutation of p53 in epithelial ovarian cancer.

  1991cited by this paper
• Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

  1990cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• Tumor suppressor genes

  1990cited by this paper
• Mutant p53—the commonest genetic abnormality in human cancer?

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• Structural aspects of the p53 protein in relation to gene evolution.

  1990cited by this paper
• p53 mutations in colorectal cancer.

  1990cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

  1988cited by this paper
• Oligomerization of oncoprotein p53

  1988cited by this paper

• High-Grade and Low-Grade Pelvic Serous Neoplasms Demonstrate Differential p53 Immunoreactivity in Peritoneal Washings

  2010cites this paper